Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Lacripep by TearSolutions for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
Lacripep is under clinical development by TearSolutions and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye). According to GlobalData,...
Data Insights
Lacripep by TearSolutions for Sicca Syndrome (Sjogren): Likelihood of Approval
Lacripep is under clinical development by TearSolutions and currently in Phase II for Sicca Syndrome (Sjogren). According to GlobalData, Phase...